Hyalose, LLC, a biotechnology company focused on the development and commercialization of novel hyaluronic acid (HA) technologies, announced today that it has selected Echelon Biosciences, Inc. of Salt Lake City, Utah, to serve as the new, sole distributor of its Select-HA products.
| AUSTIN, Texas, March 26, 2019 /PRNewswire/ -- Hyalose LLC, a biotechnology company focused on the development and commercialization of novel hyaluronic acid (HA) technologies, announced today that it has selected Echelon Biosciences Inc. of Salt Lake City, Utah, to serve as the new, sole distributor of its Select-HA products. Echelon Biosciences, a leading supplier in novel biochemical reagents, assays, and screening services, will sell Select-HA products directly from its website and through distributors worldwide. Unlike any other HA polymers available today, the Hyalose Select-HA products have very narrow size distribution ranges and discrete molecular weight ranges allowing researchers to study the physical and biological properties of defined HA compounds. Effective immediately, customers may purchase the size-defined HA standards and products at the Echelon Biosciences website. Initially, the companies will offer a variety of Select-HA products including Hi-Ladder and Lo-Ladder products, in addition to further expanded HA product offerings. W. Tim Miller, CEO and President, stated that, “Echelon Biosciences is pleased to join with Hyalose to again make these products available to HA researchers and product developers throughout the world. Echelon already has an existing and strong presence in the field with unique HA & Hyaluronidase assays and fluorescent analogs.” For more information about Select-HA products visit: www.Echelon-HA.com. About Hyalose About Emergent Technologies About Echelon Biosciences About OU College of Medicine Media Contact:
SOURCE Emergent Technologies, Inc. |
View original content:
